自体整合屏障因子1、前胶原赖氨酸2-酮戊二酸5-双加氧酶3及剪接因子3b亚基4作为肝细胞癌早期决策标志物及驱动因子
研究通过整合人类多阶段肝细胞癌组织转录组与临床病理数据,筛选出BANF1、PLOD3和SF3B4三个基因,并在大队列中验证其诊断早期肝细胞癌的能力优于现有标志物组合。靶向失活这三个基因可抑制体内外肝肿瘤发生,纳米颗粒递送siRNA可抑制小鼠肝癌发生率和生长。
要点
- BANF1、PLOD3和SF3B4在癌前病变中可检测,诊断早期肝细胞癌能力优于GPC3、GS和HSP70组合。
- 靶向失活BANF1、PLOD3和SF3B4通过调节上皮-间质转化和细胞周期蛋白抑制肝肿瘤发生。
- SF3B4过表达促使SF3b复合物将KLF4转录本剪接为非功能性外显子跳跃转录本。
核心结论
- BANF1、PLOD3和SF3B4是提示癌前病变中早期肝细胞癌的分子标志物,并可能是理解肝癌发生的驱动因子。
研究设计与样本
- 整合分析人类多阶段肝细胞癌组织(包括癌前病变、低级别和高级别不典型增生结节)的转录组与临床病理数据,设计基因筛选策略鉴定潜在驱动基因。
主要发现
- 通过免疫组化染色,在大队列肝细胞癌患者中显示BANF1、PLOD3和SF3B4诊断早期肝细胞癌的能力优于glypican 3、glutamine synthetase和heat-shock protein 70三联标志物。
- 靶向失活BANF1、PLOD3和SF3B4通过选择性调节上皮-间质转化和细胞周期蛋白,抑制体外和体内肝肿瘤发生。
- 含三个基因小干扰RNA的纳米颗粒治疗在自发小鼠肝细胞癌模型中抑制肝肿瘤发生率和肿瘤生长速率。
- SF3B4过表达触发SF3b复合物将肿瘤抑制因子KLF4转录本剪接为非功能性外显子跳跃转录本,通过转录失活p27Kip1并同时激活Slug基因促进肝细胞恶性转化和生长。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: An accurate tool enabling early diagnosis of hepatocellular carcinoma (HCC) is clinically important, given that early detection of HCC markedly improves survival. We aimed to investigate the molecular markers underlying early progression of HCC that can be detected in precancerous lesions. We designed a gene selection strategy to identify potential driver genes by integrative analysis of transcriptome and clinicopathological data of human multistage HCC tissues, including precancerous lesions, low- and high-grade dysplastic nodules. The gene selection process was guided by detecting the selected molecules in both HCC and precancerous lesion. Using various computational approaches, we selected 10 gene elements as a candidate and, through immunohistochemical staining, showed that barrier to autointegration factor 1 (BANF1), procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 (PLOD3), and splicing factor 3b subunit 4 (SF3B4) are HCC decision markers with superior capability to diagnose early-stage HCC in a large cohort of HCC patients, as compared to the currently popular trio of HCC diagnostic markers: glypican 3, glutamine synthetase, and heat-shock protein 70. Targeted inactivation of BANF1, PLOD3, and SF3B4 inhibits in vitro and in vivo liver tumorigenesis by selectively modulating epithelial-mesenchymal transition and cell-cycle proteins. Treatment of nanoparticles containing small-interfering RNAs of the three genes suppressed liver tumor incidence as well as tumor growth rates in a spontaneous mouse HCC model. We also demonstrated that SF3B4 overexpression triggers SF3b complex to splice tumor suppressor KLF4 transcript to nonfunctional skipped exon transcripts. This contributes to malignant transformation and growth of hepatocyte through transcriptional inactivation of p27Kip1 and simultaneously activation of Slug genes. CONCLUSION: The findings suggest molecular markers of BANF1, PLOD3, and SF3B4 indicating early-stage HCC in precancerous lesion, and also suggest drivers for understanding the development of hepatocarcinogenesis. (Hepatology 2018;67:1360-1377).
引用
- Shen Q, Eun JW, Lee K, et al. Barrier to autointegration factor 1, procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3, and splicing factor 3b subunit 4 as early-stage cancer decision markers and drivers of hepatocellular carcinoma. Hepatology. 2018. PMID: 29059470. doi:10.1002/hep.29606
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。